Clinical Trials on Epilepsy, Temporal Lobe in Spain

Total 185 results

Red de Terapia Celular
Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo... and other collaborators

Completed

PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells (CSM/ON/2011)

Osteonecrosis of the Femoral Head

Spain
Leonor Cuadra Llopart
Fundacio Salut i Envelliment UAB

Completed

The Effect of Supplementation of Vitamin D Deficiency in Older People With Acute Hip Fracture: (VITAMINA_D)

Vitamin D Deficiency | Hip Fracture

Spain
Zogenix International Limited, Inc., a subsidiary...

Completed

An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome

Dravet Syndrome

United States, United Kingdom, Spain, Belgium, Italy, Australia, Denmark, Germany, Canada, Japan, Netherlands, France
AO Clinical Investigation and Publishing Documentation
Synthes Inc.

Completed

Proximal Femoral Nail Antirotation™ (PFNA) Versus Gamma Nail 3™ (Gamma3) for Intramedullary Nailing of Unstable Trochanteric Fractures (PROGAINT-ES)

Unstable Trochanteric Fractures

Spain
UCB Pharma
International Bureau for Epilepsy

Completed

Adverse Event Scale in Patients With Epilepsy (aEscape) - A European Survey for Physicians With Epilepsy Patients

Epilepsy

Italy, Poland, Germany, Romania, Austria, Czech Republic, Spain
Hospital Clinic of Barcelona
Fondo de Investigacion Sanitaria; Complejo Hospitalario de Navarra; Puerta de... and other collaborators

Unknown

Care of Older People With Cognitive Impairment or Dementia Hospitalized in Traumatology Units (CARExDEM)

Dementia | Femur Fracture | Continuity of Patient Care

Spain
Amzell

Withdrawn

A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms

Spasms, Infantile

Italy, Argentina, France, United States, Spain, India, Poland, Mexico
Consorci Sanitari de Terrassa

Recruiting

Comparison of PENG Block and Fascia Iliaca Compartment Block in the Postoperative Pain Control of Hip Capsular Fracture

Hip Fractures

Spain
Eisai Inc.

Completed

4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures

Epilepsy

Belgium, France, United States, Czech Republic, Estonia, Latvia, Spain, United Kingdom, Lithuania, Germany, Australia, Finland, Netherlands, Sweden
Fundació Institut de Recerca de l'Hospital de la...

Completed

Prevention of Postoperative Bleeding in Subcapital Femoral Fractures (TRANEXFER)

Blood Loss | Hip Fracture

Spain
UCB Pharma

Completed

Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam

Epilepsy

Spain
Zogenix International Limited, Inc., a subsidiary...

Completed

A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome

Dravet Syndrome | Seizure Disorder

United States, United Kingdom, Australia, Belgium, Canada, Denmark, France, Germany, Italy, Japan, Spain
Hospital Universitario de Canarias
Orion Corporation, Orion Pharma

Completed

Preoperative levosimendán and Hip Fracture (OPL)

Ventricular Dysfunction, Left | Hip Fracture

Spain
Eisai Inc.

Completed

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Epilepsy

United States, Poland, Belgium, India, Korea, Republic of, Thailand, Hungary, Latvia, Czechia, Australia, Spain
Fundacion Miguel Servet
Hospital of Navarra; NAVARRABIOMED

Recruiting

Effect of a Multicomponent Intervention on Functional Capacity After Hip Fracture (ActiveFLS)

Hip Fractures | Osteoporosis | Rehabilitation | Fall | Frailty Syndrome

Spain
Takeda

Completed

A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome

Dravet Syndrome (DS)

China, Canada, France, Hungary, Poland, United States, Spain, Greece, Australia, Brazil, Serbia, Germany, Italy, Japan, Latvia, Netherlands, Ukraine, Russian Federation
UCB Pharma

Completed

Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures

Epilepsy

France, Poland, United Kingdom, Germany, Spain, Finland, Australia, Russian Federation, Hungary, Lithuania, Sweden, Czechia, Croatia
Hospital Viamed Valvanera, Spain
University of Navarra

Completed

Hyperprotein Nutritional Intervention in Elderly Patients With Hip Fracture and Sarcopenia (HIPERPROT)

Sarcopenia | Hip Fracture

Spain
Hospital Viamed Valvanera, Spain
University of Navarra

Completed

Prevalence and Pathophysiology of Sarcopenia in the Elderly Patient With Hip Fracture (PREFISSARC)

Frailty | Sarcopenia | Hip Fracture

Spain
Universidad Autonoma de Madrid

Completed

Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip (ORTHO-2)

Avascular Necrosis of the Femoral Head

Italy, France, Germany, Spain
UCB Pharma

Completed

Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy

Epilepsy

United States, Austria, Belgium, Canada, Czechia, Finland, France, Germany, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Netherlands, Norway, Poland, Russian Federation, Serbia, Singapore, South Africa, Spain, Sweden, Swit... and more
UCB Pharma

Completed

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam (VERVE)

Epilepsy

United States, Australia, Bulgaria, Denmark, France, Germany, Romania, Spain, Sweden
UCB Pharma SA

Completed

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

Epilepsy

United States, Belgium, Czechia, France, Germany, Hungary, Ireland, Italy, Mexico, Poland, Spain, United Kingdom
Merck Sharp & Dohme LLC

Terminated

Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)

Hip Fracture

Germany, Norway, Spain, Sweden, United Kingdom
Bial - Portela C S.A.

Completed

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Epilepsy

Spain, Bulgaria, Austria, Croatia, Czechia, France, Germany, Poland, Portugal, Romania
UCB Pharma

Completed

An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam

Epilepsy

Canada, United States, Australia, Belgium, Czechia, France, Germany, Hungary, Italy, Spain, Sweden
Neurological Institute of Athens
King's College London; Uppsala University; Rabin Medical Center; University of... and other collaborators

Recruiting

Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders (MES-CoBraD)

Epilepsy | Healthy | Sleep Disorder | Dementia | Alzheimer Disease | Circadian Rhythm Disorders

Israel, United Kingdom, Greece, Spain
UCB Pharma

Completed

Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy

Epilepsy

Australia, France, Germany, Italy, Poland, United Kingdom, Belgium, Spain, Switzerland, Austria, Bulgaria, Romania, Turkey, Denmark, Greece, Russian Federation, Netherlands, Hungary, Ireland, Slovakia, Sweden, Norway, Finland, Czech Republic
DePuy International

Terminated

An Electronic Data Capture Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Traumatic Femoral Fractures

Spain, Portugal, United Kingdom, France
Hospital de la Ribera

Unknown

Incidence of Geriatric Syndromes Overlap

Depression | Delirium | Malnutrition | Hip Fractures | GERIATRIC SYNDROMES | GERIATRIC ASSESSMENT

Spain
DePuy International

Terminated

A Multi-centre Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Traumatic Femoral Fractures

United Kingdom, Germany, Italy, Spain
Neurocrine Biosciences

Enrolling by invitation

Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep (Steamboat 2)

Epileptic Encephalopathy | Continuous Spike and Wave During Sleep

United States, Denmark, Spain, Switzerland, United Kingdom
Eisai Inc.

Completed

Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Epilepsy

Belgium, Germany, China, Hong Kong, United States, France, Romania, Mexico, South Africa, India, Portugal, Russian Federation, Italy, Canada, Australia, Taiwan, Austria, Malaysia, Hungary, Poland, Thailand, Sweden, Bulgaria, Serbia, Greece and more
GlaxoSmithKline

Completed

Pediatric Epilepsy Trial in Subjects 1-24 Months

Epilepsy

United States, Estonia, Portugal, Slovakia, Netherlands, Hungary, Italy, Lithuania, Australia, France, Spain, Latvia, Lebanon, Turkey
GlaxoSmithKline

Terminated

Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097

Epilepsy

Spain, Australia, Russian Federation, Israel, Belgium, Hungary, France, Germany, Poland, South Africa, Ukraine, United Kingdom
Neurocrine Biosciences

Completed

Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

Epileptic Encephalopathy | Continuous Spike and Wave During Sleep

United States, Denmark, Spain, Switzerland, United Kingdom, Canada
UCB Pharma SA

Completed

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Epilepsy

Belgium, Finland, France, Germany, Hungary, India, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
GlaxoSmithKline

Completed

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures (IR)

Epilepsy

Bulgaria, Belgium, Thailand, Denmark, Russian Federation, Italy, Spain, Ukraine, Netherlands, Germany, France, Poland
Takeda
Ovid Therapeutics Inc.

Completed

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies (ELEKTRA)

Epilepsy | Dravet Syndrome | Lennox-Gastaut Syndrome

United States, Canada, Israel, Poland, Spain, Australia, China, Portugal
Fundación Pública Andaluza para la gestión de la...

Completed

Efficacy of Ferric Carboxymaltose With or Without EPO Reducing Red-cell Transfusion Packs in Hip Fracture Perioperative Period (PAHFRAC)

Hip Fractures

Spain
GlaxoSmithKline
Bausch Health Americas, Inc.

Completed

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy (RESTORE2)

Seizures

Spain, Australia, Israel, Ukraine, Belgium, United States, South Africa, Hungary, United Kingdom, France, Germany, Poland, Russian Federation
UCB Pharma

Completed

Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures (PASS)

Epilepsies, Partial

France, Germany, United Kingdom, Spain, Netherlands
Abbott Nutrition

Completed

An Observational Study of a Nutritional Supplement in an Older Malnourished or at Risk of Malnutrition, Hip Fracture Population

Malnutrition

Spain
UCB BIOSCIENCES, Inc.

Completed

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy (BRITE™)

Epilepsy

Czechia, Germany, Poland, Austria, Belgium, Brazil, Canada, Estonia, Finland, France, Hong Kong, Hungary, India, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Puerto Rico, Russian Federation, Spain, Sweden, T... and more
Upsher-Smith Laboratories

Completed

Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

Epilepsy

Australia, Canada, Poland, United States, Belgium, Spain, Argentina, Israel, India, South Africa, Greece, Russian Federation, Chile, New Zealand, Germany
Upsher-Smith Laboratories

Completed

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Epilepsy

United States, Australia, Poland, Belgium, Spain, Argentina, Israel, India, South Africa, Greece, Russian Federation, Chile, Germany, New Zealand, Hungary, Canada
AO Innovation Translation Center

Completed

Geriatric Fracture Centers - Evaluation of a Geriatric Co-management Program

Hip Fractures

Singapore, Austria, Thailand, Netherlands, United States, Spain
UCB Pharma

Terminated

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Epilepsy

United States, France, Germany, Spain, Hungary, Italy
UCB BIOSCIENCES GmbH
Eden Sarl

Completed

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Epilepsy | Monotherapy

United States, Australia, Belgium, Bulgaria, Canada, Czechia, Finland, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Philippines, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Swede... and more
Takeda

Active, not recruiting

A Study of Soticlestat in Adults and Children With Rare Epilepsies (Endymion 1)

Epilepsy | Dravet Syndrome (DS) | Lennox-Gastaut Syndrome (LGS)

United States, Canada, Australia, China, Israel, Poland, Spain, Portugal

Clinical Trials on Epilepsy, Temporal Lobe in Spain

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations